114 related articles for article (PubMed ID: 32871493)
21. Placental histology and placental/fetal weight ratios in pregnant women with sickle cell disease: relationship to pregnancy outcome.
Anyaegbunam A; Mikhail M; Axioitis C; Morel MI; Merkatz IR
J Assoc Acad Minor Phys; 1994; 5(3):123-5. PubMed ID: 7949824
[TBL] [Abstract][Full Text] [Related]
22. Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation.
Korevaar TI; Steegers EA; de Rijke YB; Visser WE; Jaddoe VW; Visser TJ; Medici M; Peeters RP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1328-34. PubMed ID: 26204137
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
24. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
[TBL] [Abstract][Full Text] [Related]
25. Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.
Brittain JE; Hulkower B; Jones SK; Strayhorn D; De Castro L; Telen MJ; Orringer EP; Hinderliter A; Ataga KI
Blood; 2010 Mar; 115(10):2014-20. PubMed ID: 20040765
[TBL] [Abstract][Full Text] [Related]
26. Serum angiogenic profile in abnormal placentation.
Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
[TBL] [Abstract][Full Text] [Related]
27. The placental-umbilical unit in sickle cell disease pregnancy: a model for studying in vivo functional adjustments to hypoxia in humans.
Trampont P; Roudier M; Andrea AM; Nomal N; Mignot TM; Leborgne-Samuel Y; Ravion S; Clayton J; Mary D; Elion J; Decastel M
Hum Pathol; 2004 Nov; 35(11):1353-9. PubMed ID: 15668892
[TBL] [Abstract][Full Text] [Related]
28. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.
Gonsalves CS; Li C; Mpollo MS; Pullarkat V; Malik P; Tahara SM; Kalra VK
Biochem J; 2015 Jun; 468(3):409-23. PubMed ID: 25876995
[TBL] [Abstract][Full Text] [Related]
30. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
31. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
[TBL] [Abstract][Full Text] [Related]
32. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
33. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
Stolz M; Zeisler H; Heinzl F; Binder J; Farr A
Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274
[TBL] [Abstract][Full Text] [Related]
34. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
35. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.
Engels T; Pape J; Schoofs K; Henrich W; Verlohren S
Hypertens Pregnancy; 2013 Nov; 32(4):459-73. PubMed ID: 23957293
[TBL] [Abstract][Full Text] [Related]
36. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
[TBL] [Abstract][Full Text] [Related]
37. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
Chelli D; Hamdi A; Saoudi S; Jenayah AA; Zagre A; Jguerim H; Bedis C; Sfar E
Clin Lab; 2016 Oct; 62(10):1927-1932. PubMed ID: 28164532
[TBL] [Abstract][Full Text] [Related]
38. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes.
Chang YS; Chen CN; Jeng SF; Su YN; Chen CY; Chou HC; Tsao PN; Hsieh WS
Pediatr Neonatol; 2017 Dec; 58(6):529-533. PubMed ID: 28571908
[TBL] [Abstract][Full Text] [Related]
39. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
Kumazaki K; Nakayama M; Suehara N; Wada Y
Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
[TBL] [Abstract][Full Text] [Related]
40. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
